Clinical Trials Directory

Trials / Completed

CompletedNCT02733705

Intravenous Propofol and Fentanyl vs Propofol for Sedation in TRUS Biopsy

A Randomised Controlled Trial Comparing Combined Intravenous Propofol and Fentanyl Versus Intravenous Propofol Alone for Sedation in Patients Undergoing Transrectal Ultrasound-guided (TRUS) Prostate Biopsy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
124 (actual)
Sponsor
Mahidol University · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

Nowadays, TRUS biopsy become one of the most popular tests for diagnosis of prostate cancer. This procedure causes pain to the patients who does not received the sedative drugs or analgesic drugs. There are many ways to reduce pain and inconvenience for the patients, such as intravenous propofol, intravenous fentanyl etc. In Siriraj hospital, anesthesiologists usually give intravenous propofol with intravenous opioids but the visual analogue score after this procedure was average at 0.9-2.9. Furthermore, some systematic reviews have shown that there was no difference in pain score between periprostatic nerve block plus opioid and periprostatic nerve block only. So, this study is to find out whether opioids is need for TRUS biopsy.

Conditions

Interventions

TypeNameDescription
OTHERControlnormal saline IV
DRUGFentanylfentanyl 0.5 mcg/kg ideal BW
DRUGpropofolpropofol infusion

Timeline

Start date
2017-01-01
Primary completion
2018-05-31
Completion
2018-05-31
First posted
2016-04-11
Last updated
2021-09-01

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT02733705. Inclusion in this directory is not an endorsement.